Abstract
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Issue: Nov/Dec 2022 - Volume 26, Number 6
Page(s): 480-488
Abstract
Skin injuries, whether acute or chronic, can present therapeutic challenges engendered by wound type and etiology as well as the pharmacogenomic profile and treatment preferences of the patient. As a result, standardized manufactured medications may fail to promote healing or their use may prove intolerable (complications that impose a burden on patients and ultimately on the society in which they live and the healthcare system that supports them). For cases in which commercially available wound-healing products fail or cannot be used, a uniquely formulated pharmaceutical compound may be effective. In this article, the differences between acute and chronic dermal injuries are presented, wound infection is discussed, specific compounds designed to treatment some of the most challenging dermal-wound types are listed, and two complete formulations that have also proven safe and effective in promoting the healing of external skin damage are provided.
Related Keywords
- wound healing
- acute wounds
- chronic wounds
- inflammation
- inflammatory cytokines
- inflammatory mediators
- skin breakdown
- cytolytic enzymes
- formulations
- topical preparations
- transdermal administration
- liothyronine sodium
- timolol maleate
- wound infection
- burns
- phenytoin
- misoprostol
- lidocaine hydrochloride
- gentamicin
- arginine hydrochloride
- aloe vera
- insulin
- chronic venous stasis ulcers
- gabapentin
- ketamine hydrochloride
- prilocaine
- naltrexone hydrochloride
- ketoprofen
- sildenafil
- metronidazole
Related Categories
- DERMATOLOGY
- FORMULATIONS
- WOUND CARE
- DOSAGE FORMS/DRUG CARRIERS
- INFECTIOUS DISEASE
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Jul/Aug 2004
Pg. 269-274
|
Author(s):
Helmke Christopher D
|
Nov/Dec 2022
Pg. 480-488
|
Author(s):
Riepl Mike
|
Mar/Apr 2002
Pg. 92-95
|
Author(s):
Kincaid Michele R
|
Jul/Aug 2021
Pg. 282-287
|
Author(s):
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Author(s):
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Author(s):
Riepl Mike
|
Mar/Apr 2021
Pg. 100-103
|
Author(s):
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
Author(s):
Riepl Mike
|
May/Jun 2020
Pg. 188-193
|
Author(s):
Riepl Mike
|
Nov/Dec 2021
Pg. 468-472
|
Author(s):
Riepl Mike
|
Nov/Dec 2020
Pg. 501-508
|
|
Sep/Oct 2022
Pg. 364-368
|
Author(s):
Riepl Mike
|
Jul/Aug 2022
Pg. 270-274
|
Author(s):
Riepl Mike
|
Mar/Apr 2018
Pg. 154-163
|
|
Nov/Dec 2023
Pg. 454-460
|
|
May/Jun 2009
Pg. 196-213
|
|
Jan/Feb 2022
Pg. 18-23
|
Author(s):
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Author(s):
Riepl Mike
|
May/Jun 2018
Pg. 182-188
|
|
Mar/Apr 2020
Pg. 98-102
|
Author(s):
Riepl Mike
|